Tekcapital Plc · LSE:TEK
Tekcapital — Investor Presentation (November 2014)
18 slides from Tekcapital's investor presentation, November 2014
Slide 1: Helping clients profit from university intellectual property
! PRESENTATION Helping clients profit from university intellectual property
Slide 2: The Investment Case – A Brief Recap
! THE INVESTMENT CASE – A BRIEF RECAP Solid foundations A unique Already Experienced service for connected to Discovery Search management Engine + world- Knowledgeable corporate 3,700+ research team with >400 & successful class science transactions in acquisition of institutions in advisors board pr
Slide 3: Our Unique Service
! OUR UNIQUE SERVICE Matching client demand with a university IP solution Supply Side: The World’s 80%¹ of the Research Institutions world’s peer- File >100,000¹ new patents each year reviewed, published, academic research is produced by 3,700+ research institutions in 160 countries. Demand Side: Ou
Slide 4: The Market – Total Market Size ~£4.5bn per year
! THE MARKET – TOTAL MARKET SIZE ~£4.5BN PER YEAR1 IP acquisitive technology firms4: 2,000 UK Unique service to help 4,000 USA and Canada companies efficiently which is the initial target market enhance & protect their products with university IP Of the patents filed from Rapid Pace universities per
Slide 5: Business Model
! BUSINESS MODEL Rapidly scalable, low fixed costs & high margins Bespoke service, client driven, addressing specific needs Ongoing IP Success Search Fee Service Acquire and Transfer IP Charged upon Charged on a monthly successful completion basis of IP acquisition • Complexity of search • Complexit
Slide 6: Operational Flexibility
! OPERATIONAL FLEXIBILITY Strengthened Operational Strategic ‘go to market’ flexibility flexibility and increased opportunities Early delivery of key Ability to service wide elements of growth range of clients: strategy: • Size of company • Acquisition of • Geographical InventionEvaluator location •
Slide 7: InventionEvaluator.com
! INVENTIONEVALUATOR.COM Reports provides an objective analysis of the technology, IP and commercial potential of new IP Rationale: • An important new product that integrates with Tekcapital’s existing service offering • Able to be sold as a stand alone product • To add forward revenue and profit to t
Slide 8: Delivering against our strategy post IPO
! Delivering against our strategy post IPO • Expanded the Company’s sales and marketing team o Hired key sales and marketing executives to drive adoption ✔ o Added additional support staff to support these functions ✔ o Dr. Alan Naidoff, formerly of Merck Sharp & Dohme Corp. appointed Managing Direc
Slide 9: New North American Clients
New North American Clients ! 3 client addi+ons in the Fortune 1000 Across: Automo+ve Healthcare Food & Beverage As of Nov 20 2014, the Group had secured 15 retained clients 100% client growth since joining AIM in Q2 2014 9
Slide 10: Unrivalled access to disruptive technologies
! Unrivalled access to disrup=ve technologies Universi=es & Research Centres Innova=on Discovery Network IP Insight • Evaluate specific IP opportuni=es • Partner with Universi=es and Research Centres to purchase exclusive IP licences at low cost • License acquisi=on funded through exis=ng cash or sha
Slide 11: Summary
! SUMMARY POTENTIAL NEWSFLOW Widened Delivering service range Technology acquisitions against and strategy set extended out at IPO market InventionEvaluator presence contract wins Expanding routes to market & strategic Solid sales Clear path to alliances pipeline break-even Technology transfers Real
Slide 12: Appendices
! APPENDICES 12
Slide 13: Board of Directors
! BOARD OF DIRECTORS Clifford Gross, Chairman Cliff is a successful execu+ve with 25 years of leadership experience in academia and commercial enterprises. He is passionate about the development and commercializa+on of intellectual property to improve the quality of life and create las+ng value. Prev
Slide 14: Management Team
! MANAGEMENT TEAM Clifford M. Gross, Ph.D. Executive Chairman Selwyn Lloyd • Completed more than 100 technology transfers • Previously founded & served as CEO of Biomechanics Corp. Chief Information Officer & UTEK • Founder & Director, Phosphorix, UK • Founder & Director, OXGEOS, UK • Former Profess
Slide 15: Science Advisory Board
! SCIENCE ADVISORY BOARD Life Sciences, Electronics, Materials Science, Dr. Margot O’Toole, Translational Pharmaceuticals, Medical Medicine, Drug development, The Software & Optics Mechanical Engineering, Devices & Nutraceuticals Research Network, Former Director of Translational Medicine at Pfizer
Slide 16: Service Overview
! SERVICE OVERVIEW Sectors We Turnkey Service Cover w Continuously identify new university IP available for immediate acquisition across 3,700+ institutions in 160 Bio-Tech countries Pharmaceuticals w Science advisors screen and review every technology acquisition candidate Manufacturing w Monthl
Slide 17: How Are We Different?
! HOW ARE WE DIFFERENT? The Advantages to building a technology moat with Tekcapital “In business, I look for economic castles protected by unbreachable moats.” Warren Buffett Continuously identify new university IP available for immediate acquisition across 3,700+ institutions in 160 countries Obje
Slide 18: Our Competitive Advantage
! OUR COMPETITIVE ADVANTAGE Vs. Typical Search Results Tekcapital Search Results Typical Search Results 112 Actionable results 18,900,000 results 18